Salesforce

Immunizations

« Go Back
Information
Immunizations

HMSA Commercial plans cover immunizations in accordance with the recommendations of the Advisory Committee on Immunization Practices (ACIP).

 

ACIP Recommendations

The Advisory Committee on Immunization Practices (ACIP) develops vaccine recommendations for children and adults. The recommendations include the age(s) when the vaccine should be given, the number of doses needed, the amount of time between doses, and precautions and contraindications.

 

All of the ACIP’s recommendations are posted on the Centers of Disease Control and Prevention (CDC) webpage at:  https://www.cdc.gov/vaccines/hcp/acip-recs/.
 

COVID-19 Vaccine and Vaccine Administration codes.
For commercial members, as of 09/12/2023, COVID-19 vaccines will be commercially available and covered by HMSA. Coverage is limited to the administration codes, see COVID-19 Immunization Administration codes.


See Additional billing information .  

 

Vaccine Codes (Alphabetically ordered by Vaccine)
CodeLong DescriptionVaccine
90589Chikungunya virus vaccine, live attenuated, for intramuscular useChikungunya
90593Chikungunya virus vaccine, recombinant, for intramuscular use Chikungunya
90625Cholera vaccine, live, adult dosage, 1 dose schedule, for oral useCholera
90683Respiratory syncytial virus vaccine, mRNA lipid nanoparticles, for intramuscular useRespiratory Syncytial Virus (RSV)
90690Typhoid vaccine, live, oralTyphoid
91304Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanparticle, saponin-based adjuvant, 5 mcg/0.2 mL dosage, for intramuscular useCOVID-19 vaccine - Novavax
91318Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 3 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular useCOVID-19 vaccine – Pfizer-BioNTech
 
91319Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 10 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
91320Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
91321Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25 mL dosage, for intramuscular useCOVID-19 - Moderna
 
91322Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use
91323 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 10 mcg/0.2 mL dosage, for intramuscular use
90584Dengue vaccine, quadrivalent, live, 2 dose schedule, for subcutaneous useDengue
90587Dengue vaccine, quadrivalent, live, 3 dose schedule, for subcutaneous use
90696Diphtheria, tetanus toxoids, acellular pertussis vaccine and inactivated poliovirus vaccine, when administered to children 4 through 6 years of age, for intramuscular useDiphtheria, Tetanus, Pertussis, Poliovirus
(DTaP-IPV)
90697Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine, for intramuscular useDiphtheria, Tetanus, Pertussis, Poliovirus, Haemophilus Influenzae type B, and Hepatitis B 
(DTaP-IPV-Hib-HepB)
90698Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, for intramuscular useDiphtheria, Tetanus, Pertussis, Poliovirus, and Haemophilus influenzae type B 
(DTaP-IPV/Hib)
90700Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), when administered to individuals younger than 7 years, for intramuscular useDiphtheria, Tetanus, and Pertussis 
(DTaP)
90702Diphtheria and tetanus toxoids adsorbed when administered to individuals younger than 7 years, for intramuscular useDiphtheria and Tetanus 
(DT)
90723Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine, for intramuscular useDiphtheria, Tetanus, Pertussis , Hepatitis B, and  Poliovirus 
(DTaP-HepB-IPV)
90758Zaire ebolavirus vaccine, live, for intramuscular useEbolavirus
90647Haemophilus influenzae type b vaccine, PRP-OMP conjugate, 3 dose schedule, for intramuscular useHaemophilus influenzae type b
(Hib)
90648Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use
90632Hepatitis A vaccine (HepA), adult dosage, for intramuscular useHepatitis A
90633Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use
90634Hepatitis A vaccine (HepA), pediatric/adolescent dosage-3 dose schedule, for intramuscular use
90636Hepatitis A and hepatitis B vaccine (HepA-HepB), adult dosage, for intramuscular useHepatitis A and Hepatitis B 
90739Hepatitis B vaccine (HepB), CpG-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular useHepatitis B
90740Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use
90743Hepatitis B vaccine (HepB), adolescent, 2 dose schedule, for intramuscular use
90744Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use
90746Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use
90747Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use
90759Hepatitis B vaccine (HepB), 3-antigen (S, Pre-S1, Pre-S2), 10 mcg dosage, 3 dose schedule, for intramuscular use
90748Hepatitis B and Haemophilus influenzae type b vaccine, for intramuscular use    Hepatitis B and Haemophilus influenzae type b (Hib-HepB)
90649Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular useHuman Papillomavirus Virus
90650Human Papillomavirus vaccine, types 16, 18, bivalent (2vHPV), 3 dose schedule, for intramuscular use
90651Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use
90630Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal useInfluenza
90653Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use
90654Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use
90655Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use
90656Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use
90657Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use
90658Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use
90660Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use
90661Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use
90662Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use
90672Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use
90673Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use
90674Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use
90682 Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use
90685Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL, for intramuscular use
90686Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
90687Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use
90688Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use
90689Influenza virus vaccine, quadrivalent (IIV4), inactivated , adjuvanted, preservative, preservative free, 0.25 mL dosage, for intramuscular use
90694Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use
Q2034Influenza virus vaccine, split virus, for intramuscular use (Agriflu)
Q2035Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (AFLURIA)
Q2036Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (FLULAVAL)
Q2037Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (FLUVIRIN)
Q2038Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Fluzone)
90738Japanese encephalitis virus vaccine, inactivated, for intramuscular useJapanese Encephalitis
 
90707Measles, mumps and rubella virus vaccine, live, for subcutaneous useMeasles, Mumps, Rubella
(MMR)
90710Measles, mumps, rubella, and varicella vaccine, live, for subcutaneous useMeasles, Mumps, Rubella and Varicella
(MMRV)
90623Meningococcal pentavalent vaccine, conjugated Men A, C, W, Y-tetanus toxoid carrier, and Men B-FHbp, for intramuscular useMeningococcal  
(MENACWY-TT MENB-FHBP)
90624Meningococcal pentavalent vaccine, conjugated Men A, C, W, Y-tetanus toxoid carrier, and Men B-FHbp, for intramuscular useMeningococcal  
90619Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier, for intramuscular useMeningococcal and Tetanus
(MENACWY-TT)
90620Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B, 2 dose schedule, for intramuscular useMeningococcal 
(MenB-4C)
90621Meningococcal recombinant lipoprotein vaccine, serogroup B, 2 or 3 dose schedule, for intramuscular useMeningococcal 
(MenB-FHbp)
 
90644Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type B vaccine, 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular useMeningococcal and Haemophilus influenzae type B 
(Hib-MENCY)
 
90733Meningococcal polysaccharide vaccine serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier or CRM197 carrier, for intramuscular useMeningocococcal
Polysaccharide
(MPSV4)
 
90734Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier or CRM197 carrier (MenACWY-CRM), for intramuscular useMeningococcal ACWY
Pneumococcal conjugate
(MENACWY-D)
90670Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular usePneumococcal conjugate
90671Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use
90677Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use
90684Pneumococcal conjugate vaccine, 21 valent (PCV21), for intramuscular use
90732Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or intramuscular usePneumococcal polysaccharide
(PPSV23)
90713Poliovirus vaccine, inactivated, for subcutaneous or intramuscular usePoliovirus
(IPV)
90380Respiratory syncytial virus, monoclonal antibody, seasonal dose; 0.5 mL dosage, for intramuscular useRespiratory Syncytial Virus (RSV)
90381Respiratory syncytial virus, monoclonal antibody, seasonal dose; 1 mL dosage, for intramuscular use
90382Respiratory syncytial virus, monoclonal antibody, seasonal dose, 0.7 mL, for intramuscular use
90678Respiratory syncytial virus vaccine, preF, subunit, bivalent, for intramuscular use
90679Respiratory syncytial virus vaccine, preF, recombinant, subunit, adjuvanted, for intramuscular use
90680Rotavirus vaccine, pentavalent, 3 dose schedule, live, for oral useRotavirus
(RV5)
90681Rotavirus vaccine, human, attenuated, 2 dose schedule, live, for oral useRotavirus
(RV1)
90714Tetanus and diphtheria toxoids adsorbed (Td), preservative free, when administered to individuals 7 years or older, for intramuscular useTetanus and diphtheria
(Td)
90715Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular useTetanus, Diphtheria, and Pertussis 
(Tdap)
 
90626Tick-borne encephalitis virus vaccine, inactivated; 0.25 mL dosage, for intramuscular useTick-borne encephalitis
90627Tick-borne encephalitis virus vaccine, inactivated; 0.5 mL dosage, for intramuscular use
90691Typhoid vaccine, Vi capsular polysaccharide, for intramuscular useTyphoid
(ViCPs)
90716Varicella virus vaccine, live, for subcutaneous useVaricella 
(VAR
90717Yellow fever vaccine, live, for subcutaneous useYellow fever
90736Zoster (shingles) vaccine, live, for subcutaneous injectionZoster 
(HZV)
90750Zoster (shingles) vaccine, recombinant, subunit, adjuvanted, for intramuscular use



 

Vaccine Administration Codes
CodeLong DescriptionUsed for
90460Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered0 through 18 years; first or only component of each vaccine or toxoid administered
90461Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure)0 through 18 years; each additional vaccine or toxoid component administered
90471Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)1 vaccine (single or combination vaccine/toxoid)
90472Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)Each additional vaccine (single or combination vaccine/toxoid)
90473Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid)Administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid)
90474Immunization administration by intranasal or oral route; each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)Administration by intranasal or oral route; each additional vaccine (single or combination vaccine/toxoid)
90480Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single doseCovid-19 Administration code
(i.e. 91318, 91319, 91320, 91321, & 91322)
96380Administration of respiratory syncytial virus, monoclonal antibody, seasonal dose by intramuscular injection, with counseling by physician or other qualified health care professionalRespiratory Syncytial Virus administration code 
(i.e. used with 90380 or 90381)
96381Administration of respiratory syncytial virus, monoclonal antibody, seasonal dose by intramuscular injection
G0008Administration of influenza virus vaccine 
G0009Administration of pneumococcal vaccine 
G0010Administration of hepatitis B vaccine 




The original monovalent vaccines' emergency use authorization (EUA) has been rescinded and those vaccines are no longer recommended for use, effective November 1, 2023
 

Deleted Codes as of November 1, 2023
COVID-19 Vaccine CodesCOVID-19 Vaccine Administration CodesManufacturer
91300 0001A (1st dose)
0002A (2nd dose)
0003A (3rd dose)
0004A (Booster)
Pfizer, Inc
913010011A (1st dose)
0012A (2nd dose)
0013A (3rd dose)
Moderna, Inc
913020021A (1st dose)
0022A (2nd dose)
Astra Zeneca, Plc
913030031A (1st dose)
0034A (2nd dose)
Janssen
913050051A (1st dose)
0052A (2nd dose)
0053A (3rd dose)
0054A (Booster)
Pfizer, Inc
913060064A (Booster)Moderna, Inc
913070071A (1st dose)
0072A (2nd dose)
0073A (3rd dose)
0074A (Booster)
Pfizer, Inc
913080081A (1st dose)
0082A (2nd dose)
0083A (3rd dose)
Pfizer, Inc
913090091A (1st dose)
0092A (2nd dose)
0093A (3rd dose)
0094A (Booster)
Moderna, Inc
913100104A (Booster)Sanofi Pasteur
913110111A (1st dose)
0112A (2nd dose)
0113A (3rd dose)
Moderna, Inc
913120121A (1st dose)
0124A (Additional dose)
Pfizer, Inc
913130134A (Additional dose)Moderna, Inc
913140141A (1st dose)
0142A (2nd dose)
0144A (Additional dose)
Moderna, Inc
913150151A (1st dose)
0154A (Additional dose)
Pfizer, Inc
913160164A (Additional dose)Moderna, Inc
913170171A (1st dose)
0172A (2nd dose)
0173A (3rd dose)
0174A (Additional dose)
Pfizer, Inc
N/A0041A (1st dose)
0042A (2nd dose)
0044A (3rd dose)
Novavax, Inc

 


Please be sure to use the most up-to-date industry-standard procedure, revenue, and diagnosis codes from the current CPT ®′′, HCPCS Level II, and ICD-10-CM manuals, as recommended by the American Medical Association (AMA), the Centers for Medicare & Medicaid Services (CMS), and the American Hospital Association.

 

Codes may not be all inclusive as the AMA and CMS code updates may occur more frequently.

 

 

Claim Billing Examples • ♦

♦ CPT, diagnosis codes and ACIP recommendations are subject to change and are used as reference examples only.


EXAMPLE 1

ACIP Hepatitis B recommendation state “all adults requesting protection from HBV infection, without requiring them to acknowledge a specific factor” should be vaccinated.
Adult member presents to a physician office requesting the Hepatitis B vaccination. The adult member does not disclose a specific risk factor and is not required.

 

Diagnosis:

  • Z23 - Encounter for immunization

Code:

  • 90746 - Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use
  • 90471 – Immunization Administration

Modifier:

  • No modifier necessary

 

 

EXAMPLE 2

ACIP Hepatitis A recommendation states “persons with end-stage renal disease, including predialysis, hemodialysis, peritoneal dialysis, and home dialysis patients” should be vaccinated.
Adult member presents to a physician office for Hepatitis A vaccine because the member is considered a high risk candidate due to End Stage Renal Disease. 

 

Diagnosis:

  • N18.6 - End stage renal disease
  • Z99.2 - Dependence on renal dialysis
  • Z23 -  Encounter for immunization

 Code:

  • 90632 - Hepatitis A vaccine (HepA), adult dosage, for intramuscular use
    • Append modifier SK
  • 90471 – Immunization Administration

Modifier:

  • SK - Member of high risk population (use only with codes for immunization)

 

EXAMPLE 3

ACIP recommendation states, “pregnant people during 32 through 36 weeks gestation, using seasonal administration, to prevent RSV lower respiratory tract infection in infants” should be vaccinated.   Member informs physician or other qualified healthcare professional provider that they are 33 weeks gestation. 


Diagnosis:

  • Z23 -  Encounter for immunization
  • Z3A.33 - 33 weeks gestation of pregnancy


Code:

  • 90678 – Respiratory syncytial virus vaccine, preF, subunit, bivalent, for intramuscular use
  • 90471 – Immunization Administration

   

Additional Billing Information • ♣ ♦

  • Bill the procedure code(s) representing the vaccine/toxoid and the appropriate administration code (s) on the same claim.
  • HMSA prefers that a provider bills administration codes on a single line with a count (# of units).
  • HMSA does not pay for vaccines provided by the State. Vaccines provided by the state should append modifier SL (State supplied vaccine) on the vaccine claim line with a nominal bill charge of $0.00.  Note: IF system is limited and a charge is required, bill charge at $0.01.
  • We encourage billing the COVID -19 vaccine & vaccine administration separately from other services rendered in the same visit.
  • During the public health emergency (PHE) period, COVID-19 vaccines are funded by the federal government. Therefore, you are not required to bill for the COVID-19 vaccines (CPT 91300, 91301, or 91303).
  • According to Noridian, UB claims billed for COVID-19 vaccine administration shall be billed with revenue code 0771 (Preventive Care Services – Vaccine Administration).  Using other revenue codes may result to bundling into a case rate.
  • Report CPT codes 90460 and 90461 only when the physician or other qualified healthcare professional provides face-to-face counseling to the patient/family during the vaccine administration.
  • Code 90460 is reported once for the first component of each vaccine or toxoid administered by any route.
  • Code 90461 is additionally reported for the counseling associated with each additional component of any combination vaccine or toxoid.
  • A component refers to all antigens in a vaccine that prevents disease(s) caused by one organism. Multivalent antigens or multiple serotypes of antigens against a single organism are considered a single component of vaccines. Combination vaccines are those vaccines that contain multiple vaccine components. Conjugates or adjuvants in vaccines are not considered parts of the vaccine as defined above. See the reference table below.
  • For more related information about vaccine and administration, refer to Immunization Administration Billed with Other Services for more related information.
  • According to ACIP, effective September 22, 2023, * Maternal RSV vaccine is recommended for pregnant people during 32 through 36 weeks of gestation. Be sure to indicate the appropriate diagnosis code for the weeks of gestation. (e.g. Z3A.32, Z3A.33, Z3A.34, Z3A.35, or Z3A.36). Refer to https://www.cdc.gov/vaccines/hcp/acip-recs/ for the latest ACIP recommendation.

  

Components of Common Pediatric Vaccines

 

VaccineNumber of Vaccine ComponentsImmunization Adminstration Codes(s) Reported
Haemophilus influenzae type b - Hib190460
Human Papillomavirus Virus190460
Influenza190460
Meningococcal190460
Pneumococcal190460
Rotavirus190460
Haemophilus influenzae type b / Hepatitis B - (HepB-Hib)290460, 90461
Tetanus and Diphtheria (Td)290460, 90461
Diphtheria, Tetanus and Pertussis (DTaP)390460, 90461 x 2
Tetanus, Diphtheria, and Pertussis (Tdap)390460, 90461 x 2
Haemophilus influenzae type b - Hib190460
Diphtheria, Tetanus and Pertussis (DTaP) / Polio - (DTaP-IPV)490460, 90461 x 3
Diphtheria, Tetanus and Pertussis (DTaP) / Polio / Haemophilus influenzae type - (DTaP-Hib)490460, 90461 x 3
Measles, Mumps, Rubella and Varicella (MMRV)490460, 90461 x 3
Diphtheria, Tetanus and Pertussis (DTaP) / Hepatitis B / Polio - (DTaP-HepB-IPV)590460, 90461 x 4
Diphtheria, Tetanus and Pertussis (DTaP) / Polio / Haemophilus influenzae type b - (DTaP-IPV/Hib)590460, 90461 x 4

 


Please be sure to use the most up-to-date industry-standard procedure, revenue, and diagnosis codes from the current CPT ®′′, HCPCS Level II, and ICD-10-CM manuals, as recommended by the American Medical Association (AMA), the Centers for Medicare & Medicaid Services (CMS), and the American Hospital Association.

Codes may not be all inclusive as the AMA and CMS code updates may occur more frequently.

CPT, diagnosis codes and ACIP recommendations are subject to change and are used as reference examples only.


 

BCIS
 
Rev#:Date:Nature of Change:
3.0410/02/20251100-1205563-1545950 Moved the new codes to be listed by type of vaccines.
3.0310/01/20251100-1205563-1545950 The following codes and descriptions have been added:
90624    Meningococcal pentavalent vaccine, conjugated Men A, C, W, Y-tetanus toxoid carrier, and Men B-FHbp, for intramuscular use, Meningococcal  
90382    Respiratory syncytial virus, monoclonal antibody, seasonal dose, 0.7 mL, for intramuscular use, Respiratory Syncytial Virus (RSV)
3.0209/11/20251100-1205556-1514650 The following code and description has been added to the vaccine codes list: 
COVID-19 - Moderna: 91323 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 10 mcg/0.2 mL dosage, for intramuscular use 
3.0106/16/2025

The following codes were added to the Vaccine Codes list: 

90593 Chikungunya virus vaccine, recombinant, for intramuscular use 

90683 Respiratory syncytial virus vaccine, mRNA lipid nanoparticles, for intramuscular use 

90690 Typhoid vaccine, live, oral 

3.003/20/20251100-1205514-1283650 Added: 90684 Pneumococcal conjugate vaccine, 21 valent (PCV21), for intramuscular use
2.27 (v38)05/24/20241100-956522-1060955
Added codes: 90623, 90626, 90627
2.26 (v37)10/13/2023Few minor edits adding "Long" to Description column for both tables (Vaccine Codes (Alphabetically ordered by Vaccine) Table and Vaccine Administration Code Table
Removing Inactivated in Inactivated Influenza and added RSV to Respiratory Syncytial Virus under the Vaccine column in Vaccine Codes (Alphabetically ordered by Vaccine) Table
2.25 (v36)10/13/2023Replaced Vaccine Codes (Alphabetically ordered by Vaccine) Table -  multi changes to Code, Description and Vaccine column
Replaced Immunization Administration Table with Vaccine Administration Code Table - multi changes to Code, Description and Used for column
2.24 (v35)10/11/2023Updated Vaccine Codes Table: moved codes around to list them in alphabetical order by vaccines
Added Under Immunization Administration Table codes 96380 & 96381
Claim Billing Examples (Added Example 3)
Added information on last bullet point under Additional Billing Information
2.23 (v34)10/03/2023Added *Maternal to the description for codes 90380 and 990381. 
Added the following bullet to the Additional Billing Information section:
According to ACIP, effective September 22, 2023, *Maternal RSV vaccine is recommended for pregnant people during a specific week of gestation.  Be sure to indicate the appropriate diagnosis code for the weeks of gestation.
2.22 (v33)09/27/2023Information regarding the COVID-19 Vaccine and Vaccine Administration codes were updated.
The following vaccine codes were removed:
*91300, *91301, 91303, 91305, *91306, *91307, *91308, *91309, *91311, 91312, 91313, 91314, 91315
The following immunization administration codes were removed:
*0001A, *0002A, *0003A, *0004A, *0011A, *0012A, *0013A, 0031A, 0034A, 0041A, 0042A, 0044A, *0051A, *0052A, *0053A, *0054A, *0064A, *0071A, *0072A, *0073A, *0074A, *0081A, *0082A, *0083A, *0091A, *0092A, *0093A, *0094A, *0111A, *0112A, *0113A, 0121A, 0124A, 0134A, 0141A, 0142A, 0144A, 0151A, 0154A, 0164A, 0171A, 0172A, 0173A, 0174A
Added a table of the original COVID-19 vaccine & vaccine administration codes are no longer recommended for use effective November 1, 2023.
2.21 (v32)09/21/2023The following have been posted:
91318 SARSCOV2 VACCINE 3MCG TRS-SUC IM Coronavirus vaccine - Pfizer-BioNTech
91319 SARSCV2 VACCINE 10MCG TRS-SUC IM Coronavirus vaccine - Pfizer-BioNTech
91320 SARSCV2 VACCINE 30MCG TRS-SUC IM Coronavirus vaccine - Pfizer-BioNTech
91321 SARSCOV2 VACCINE 25 MCG/.25ML IM Coronavirus vaccine - Moderna
91322 SARSCOV2 VACINEC 50 MCG/0.5ML IM Coronavirus vaccine - Moderna
90480 ADMIN SARSCOV2 VACC 1 DOSE Covid-19 Administration code
2.20 (v31)08/09/2023The following have been posted:
90380    RSV MONOC ANTB SEASN .5ML IM, Respiratory Syncytial Virus (RSV) 
(Pediatric Use Only)
90381    RSV MONOC ANTB SEASN 1ML IM, Respiratory Syncytial Virus (RSV) 
(Pediatric Use Only)
 
2.19 (v30)08/01/2023The following have been posted:
90678 RSV VACC PREF BIVALENT IM, Respiratory Syncytial Virus vaccine
90679 RSV VACC PREF RECOMB ADJT IM, Respiratory Syncytial Virus vaccine
2.18 (v29)05/08/2023A note was added regarding the original vaccines.
Asterisk removed from the following codes and description modified if applicable:
91303, 91304, 91312, 91313, 91314, 91315, 0031A, 0034A, 0041A, 0042A, 0044A, 0124A, 0134A, 0144A, 0154A, 0164A, 0173A, 0174A
Added codes: 0121A, 0141A, 0142A, 0151A, 0171A, 0172A
2.17 (v28)04/17/2023The following have been posted:
*0164A    IMMUNIZATION ADMIN BVL BOOSTER    Moderna Bivalent Booster
(Pediatric Use Only – 6 months through 5 years of age)
*0173A    IMMUNIZATION ADMIN 3RD DOSE    Pfizer-BioNTech Bivalent Administration code
(Pediatric Use Only – 6 months through 4 years of age)
*0174A    IMMUNIZATION ADMIN BVL BOOSTER    Pfizer-BioNTech Bivalent Booster
(Pediatric Use Only – 6 months through 4 years of age)
2.16 (v27)10/27/2022The following has been posted:
*0044A IMMUNIZATION ADMIN BOOSTER DOSE Novavax
2.15 (v26)10/17/2022The following revisions were posted:
Vaccine Codes section, under *91311, age criteria has changed from 4 => 5 years old.
Immunization Administration section, the 3rd column under rows *0111A, *0112A, *0113A, age criteria has changed from 4 => 5 years old.
2.14 (v25)10/14/2022The following codes were added:
*91314    SARCOV2 VACCINE BIVALENT 25 MCG/0.25 ML IM USE    Coronavirus vaccine – Moderna
(Pediatric Use Only – 6 years through 11 years of age)
*91315    SARCOV2 VACCINE BIVALENT 10 MCG/0.2 ML IM USE    Coronavirus vaccine – Pfizer-BioNTech
(Pediatric Use Only – 5 years through 11 years of age)
*0144A    IMMUNIZATION ADMIN BVL BOOSTER     Moderna Bivalent Booster
(Pediatric Use Only – 6 years through 11 years of age)
*0154A    IMMUNIZATION ADMIN BVL BOOSTER    Pfizer-BioNTech Bivalent Booster
(Pediatric Use Only – 5 years through 11 years of age)
2.13 (v24)09/08/2022The following vaccine codes were added:
*91312    SARSCOV2 BVL VACCINE 30 MCG/0.3 ML IM USE    Coronavirus bivalent booster vaccine – Pfizer-BioNTech 
*91313    SARSCOV2 BVL VACCINE 50 MCG/0.5 ML IM USE    Coronavirus bivalent booster vaccine – Moderna
*0124A    IMMUNIZATION ADMIN BVL BOOSTER    Pfizer-BioNTech Bivalent Booster 
*0134A    IMMUNIZATION ADMIN BVL BOOSTER    Moderna Bivalent Booster
2.12 (v23)07/29/2022Added codes: *91304, *0041A *0042A, *0091A, *0092A, *0093A, *0113A
Revised: *91306, *91309, *91311, *0051A, *0052A, *0053A, *0094A
2.11 (v22)06/23/2022The following vaccine name has been updated:
Pfizer-BioNTech COVID-19 Vaccine (Pediatric Use Only – 5 through 11 years of age)
The following administration codes have been added:
Pfizer-BioNTech COVID-19 Vaccine (Pediatric Use Only – 6 months through 4 years of age): 0081A (1st Dose), 0082A (2nd Dose), 0083A (3rd Dose)
Moderna COVID-19 Vaccine (Pediatric Use Only – 6 months through 4 years of age): 0111A (1st Dose), 0112A (2nd Dose)
2.10 (v21)06/22/2022The following code has been updated:
*91307 SARSCOV2 VACCINE 10 MCG/0.2 ML IM USE Coronavirus vaccine – Pfizer-BioNTech (Pediatric Use Only – 5 through 11 years of age)
The following code has been added:
*91308 SARSCOV2 VACCINE 3 MCG/0.2 ML IM USE    Coronavirus vaccine – Pfizer-BioNTech (Pediatric Use Only – 6 months through 4 years of age)
*91311    SARSCOV2 VACCINE .25 MCG/0.25 ML IM USE    Coronavirus vaccine – Moderna 
(Pediatric Use Only – 6 months through 4 years of age)
2.9 (v20)05/31/2022Added the following vaccine code:
*0074A IMMUNIZATION ADMIN BOOSTER DOSE, Pfizer-BioNTech Administration codes (Pediatric Use Only)
2.8 (v19)04/05/2022Added the following Vaccine code:
*91309  SARSCOV2 VACCINE 50 MCG/0.5 ML IM USE, Coronavirus vaccine - Moderna (Booster, 2nd dose)
Added the following Immunization Administration code:
 
*0094A IMMUNIZATION ADMIN BOOSTER 2ND DOSE, Moderna Administration 2nd Booster code
2.7 (v18)01/31/2022Added code *0054A, IMMUNIZATION ADMIN BOOSTER DOSE - Pfizer-BioNTech Administration codes (Tris-Sucrose formulation)
2.6 (v17)01/25/2022Added new COVID-19 vaccine codes 91305, 0051A, 0052A, 0053A, and 0073A
2.5 (v16)11/04/2021Added the following Vaccine code:
*91307 Coronavirus vaccine – Pfizer-BioNTech (Pediatric Use Only)
Added the following Immunization Administration codes:
*0071A, *0072A Pfizer-BioNTech Administration codes (Pediatric Use Only)
2.4 (v15)11/03/2021Added the following code: *0034A (Janssen) - BOOSTER
Removed the following codes: *91302 (AstraZeneca), *91304 (Novavax), *0021A (AstraZeneca), *0022A (AstraZeneca), *0041A (Novavax), *0042A (Novavax)
2.3 (v14)10/22/2021Added codes: 91306 - Moderna Booster; 90671 and 90677 - Pneumococcal conjugate; *0064A - Moderna Administration Booster dose
2.2 (v13)09/30/2021Added code *0004A Pfizer-BioNTech Administration Booster dose
2.1 (V12)08/18/2021Updates made under the Immunization Administration section to include the additional 3rd dose for Pfizer and Moderna vaccine administration.
2.0 (v11)07/01/2021The entire contents of the Vaccine Codes table has been updated and replaced. 

 

Rev#:Date:Nature of Change:
1.011/16/2017Fixed broken link in Hemophilus Influenza B Vaccines - OBSOLETE.
1.207/28/2020Added G0010 ADMIN HEPATITIS B VACCINE
1.309/08/2020Added code 60694 AIIV4 ANJUVANTED, PRSV FREE 0.5 ML IM (FLUAD)
1.412/16/2020Updates regarding COVID-19 Added codes for Pfizer-BioTech and Moderna. Reformatting of Claim Billing Examples.
1.512/23/2020Added codes for AstraZeneca. 91302, 0021A, 0022A.
1.603/02/2021Added code for Janssen: *91303, *0031A.
1.703/25/2021The content under the Additional Billing Information section has been updated.
1.803/28/2021Minor formatting revisions under the Additional Billing Information section.
1.905/10/2021Added codes for Novavax: *91304, *0041A, *0042A.
1.1005/17/2021Updated the content under the Additional Billing Information section.


 

Details
Immunizations

Powered by